Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Deliveliotis

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|February 27, 1999
Risk factors for prostate cancer: a case-control study in GreeceC C Hsieh, A Thanos, D Mitropoulos, et al.
World Journal of Urology|July 5, 2003
The prognostic value of p53 and DNA ploidy following radical prostatectomyC Deliveliotis, A Skolarikos, A Karayannis, et al.
Urologia Internationalis|January 1, 1995
Subcapsular hematoma due to ESWL: risk factors. A study of 4,247 patientsA Kostakopoulos, N J Stavropoulos, C Macrychoritis, et al.
Andrologia|May 4, 2006
Can prostate biopsies affect erectile function?M Chrisofos, A G Papatsoris, A Dellis, et al.
International Urology and Nephrology|February 7, 2001
Multiple transrectal ultrasound guided prostatic biopsies: morbidity and toleranceC Deliveliotis, V John, G Louras, et al.
The Journal of Urology|June 1, 1996
Primary renal lymphoma: a clinical and radiological studyM A Dimopoulos, L A Moulopoulos, C Costantinides, et al.
British Journal of Urology|May 1, 1995
The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek viewC Deliveliotis, G Alivizatos, A Karayiannis, et al.
Urological Research|July 20, 2004
DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladderC Deliveliotis, J Georgoulakis, A Skolarikos, et al.
European Urology|August 13, 2004
Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term resultsA Bamias, C Deliveliotis, A Karayiannis, et al.
Urologia Internationalis|January 1, 1994
Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigenC Deliveliotis, G Alivizatos, N J Stavropoulos, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|February 27, 1999
Risk factors for prostate cancer: a case-control study in GreeceC C Hsieh, A Thanos, D Mitropoulos, et al.
World Journal of Urology|July 5, 2003
The prognostic value of p53 and DNA ploidy following radical prostatectomyC Deliveliotis, A Skolarikos, A Karayannis, et al.
Urologia Internationalis|January 1, 1995
Subcapsular hematoma due to ESWL: risk factors. A study of 4,247 patientsA Kostakopoulos, N J Stavropoulos, C Macrychoritis, et al.
Andrologia|May 4, 2006
Can prostate biopsies affect erectile function?M Chrisofos, A G Papatsoris, A Dellis, et al.
International Urology and Nephrology|February 7, 2001
Multiple transrectal ultrasound guided prostatic biopsies: morbidity and toleranceC Deliveliotis, V John, G Louras, et al.
The Journal of Urology|June 1, 1996
Primary renal lymphoma: a clinical and radiological studyM A Dimopoulos, L A Moulopoulos, C Costantinides, et al.
British Journal of Urology|May 1, 1995
The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek viewC Deliveliotis, G Alivizatos, A Karayiannis, et al.
Urological Research|July 20, 2004
DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladderC Deliveliotis, J Georgoulakis, A Skolarikos, et al.
European Urology|August 13, 2004
Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term resultsA Bamias, C Deliveliotis, A Karayiannis, et al.
Urologia Internationalis|January 1, 1994
Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigenC Deliveliotis, G Alivizatos, N J Stavropoulos, et al.
Pageof 9